v3.26.3
SEGMENT INFORMATION (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Measure of Segment Profit or Loss The primary measure of segment profit or loss is consolidated net income as presented below and is used by the CEO for the purpose of evaluating segment performance and allocation of budget to support business expansion, new product development and operational efficiencies.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
(In thousands)
Net revenues$293,329 $410,427 $868,083 $1,129,664 
Less:
Other cost of revenues(1)
219,931 276,115 653,459 759,569 
Fair value of AMPTC generated(58,615)(67,627)(178,129)(182,298)
Loss from sale of AMPTC generated during 2025— — 18,905 — 
Tariff refunds(2)
120 — (43,291)— 
Stock-based compensation expense43,043 51,469 135,588 160,998 
Acquisition related expenses and amortization(3)
3,998 4,487 13,417 13,383 
Other restructuring and asset impairment(4)
(52)1,287 4,581 7,183 
Other research and development(5)
28,074 26,778 82,196 80,245 
Other sales and marketing(6)
29,478 31,044 90,580 91,921 
Other general and administrative(7)
20,886 20,715 62,435 63,575 
Income from operations6,466 66,159 28,342 135,088 
Total other income (expense), net(10,037)10,860 16,126 31,029 
Income (loss) before income taxes(3,571)77,019 44,468 166,117 
Income tax benefit (provision)26,958 (10,381)7,592 (32,697)
Net income $23,387 $66,638 $52,060 $133,420 
(1)    Represents consolidated cost of revenue excluding stock-based compensation, acquisition related amortization, fair value of AMPTC generated, loss from sale of AMPTC generated during 2025 and IEEPA tariff refunds.
(2)    Of the approximately $1.6 million and approximately $47.0 million refunds recognized as a reduction to cost of revenues in the three and nine months ended September 30, 2026, respectively, approximately, $43.3 million of the tariff costs incurred were previously recorded as a cost of revenues in prior periods.
(3)    Represents costs incurred in connection with acquisition-related activities, which are not indicative of normal, recurring operating expenses, and acquisition related amortization.
(4)    Represents consolidated restructuring and asset impairment excluding stock-based compensation.
(5)    Represents consolidated research and development excluding stock-based compensation.
(6)    Represents consolidated sales and marketing excluding stock-based compensation and acquisition related amortization.
(7)    Represents consolidated general and administrative excluding stock-based compensation and acquisition related expenses.